BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 18786563)

  • 61. Effect of Jak2 kinase inhibition on Stat1 and Stat3 activation and apoptosis of tubular epithelial cells induced by ATP depletion/recovery.
    Wang J; Ouyang C; Chen X; Fu B; Lu Y; Hong Q
    J Nephrol; 2008; 21(6):919-23. PubMed ID: 19034877
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
    Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
    FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protection of the ischemic heart: the role of pre- and postconditioning.
    Philipp S; Kordish I; Sack S; Erbel R
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):26-8. PubMed ID: 19618596
    [No Abstract]   [Full Text] [Related]  

  • 64. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver.
    Tiberio L; Tiberio GA; Bardella L; Cervi E; Cerea K; Dreano M; Garotta G; Fra A; Montani N; Ferrari-Bravo A; Callea F; Grigolato P; Giulini SM; Schiaffonati L
    Cytokine; 2006 May; 34(3-4):131-42. PubMed ID: 16814559
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adenosinergic cardioprotection: multiple receptors, multiple pathways.
    Peart JN; Headrick JP
    Pharmacol Ther; 2007 May; 114(2):208-21. PubMed ID: 17408751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Signalling pathways mediating inflammatory responses in brain ischaemia.
    Planas AM; Gorina R; Chamorro A
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1267-70. PubMed ID: 17073799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. STAT3-mediated activation of myocardial capillary growth.
    Hilfiker-Kleiner D; Limbourg A; Drexler H
    Trends Cardiovasc Med; 2005 May; 15(4):152-7. PubMed ID: 16099380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3).
    Fitzgerald JS; Poehlmann TG; Schleussner E; Markert UR
    Hum Reprod Update; 2008; 14(4):335-44. PubMed ID: 18424427
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine.
    Kimura R; Maeda M; Arita A; Oshima Y; Obana M; Ito T; Yamamoto Y; Mohri T; Kishimoto T; Kawase I; Fujio Y; Azuma J
    Cytokine; 2007 May; 38(2):107-15. PubMed ID: 17629706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of Cardiovascular Risk Factors on Cardiac STAT3.
    Pipicz M; Demján V; Sárközy M; Csont T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424579
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological preconditioning with phosphodiestrase inhibitor: an answer to stem cell survival against ischemic injury through JAK/STAT signaling.
    Yadav M; Kumari P; Yadav V; Kumar S
    Heart Fail Rev; 2020 Mar; 25(2):355-366. PubMed ID: 31309353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.
    Fujio Y; Maeda M; Mohri T; Obana M; Iwakura T; Hayama A; Yamashita T; Nakayama H; Azuma J
    J Pharmacol Sci; 2011; 117(4):213-22. PubMed ID: 22056652
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Artesunate obliterates experimental hepatocellular carcinoma in rats through suppression of IL-6-JAK-STAT signalling.
    Ilamathi M; Prabu PC; Ayyappa KA; Sivaramakrishnan V
    Biomed Pharmacother; 2016 Aug; 82():72-9. PubMed ID: 27470341
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular mechanism of preconditioning.
    Das M; Das DK
    IUBMB Life; 2008 Apr; 60(4):199-203. PubMed ID: 18344203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Egr-1 functions as a master switch regulator of remote ischemic preconditioning-induced cardioprotection.
    Billah M; Ridiandries A; Rayner BS; Allahwala UK; Dona A; Khachigian LM; Bhindi R
    Basic Res Cardiol; 2019 Dec; 115(1):3. PubMed ID: 31823016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiple roles of STAT3 in cardiovascular inflammatory responses.
    Lim CP; Fu XY
    Prog Mol Biol Transl Sci; 2012; 106():63-73. PubMed ID: 22340714
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC.
    Wang S; Zhang W
    Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167
    [TBL] [Abstract][Full Text] [Related]  

  • 80. STAT3 signaling and the hyper-IgE syndrome.
    Levy DE; Loomis CA
    N Engl J Med; 2007 Oct; 357(16):1655-8. PubMed ID: 17881746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.